Auto-generated challenge from hypothesis h-var-a0933e666d (score=0.824). Target: AIM2, CASP1, IL1B, PYCARD, TARDBP. Question: Can targeting Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neuro lead to therapeutic benefit in neurodegeneration? Falsifiable prediction: NLRP3 inhibition will reduce neuroinflammation and prevent neuronal loss.